Maternal screening could help prevent deadly forms of leukemia
A deadly form of leukemia may be stopped before it ever develops by introducing targeted maternal screening in…
Study maps the evolution of myeloid leukemia in children with Down syndrome
It may be possible to identify which pre-cancerous cells will develop into a rare type of blood cancer,…
Study finds increasing rates of therapy-related acute myeloid leukemia
Some therapies used to treat cancer may increase the risk of later developing cancers that affect the blood.…
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by…
Acute Myeloid Leukemia Fought With New AI Tool
Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages.…
Engineered Listeria boosts innate immunity against cancer
After nearly 40 years of research on how Listeria bacteria manipulate our cells and battle our immune system…
Researchers Raise Concerns about Faster Aging, Possible Early-Onset Dementia, for Children and Young Adult Cancer Survivors
Adolescent and young adult cancer survivors age faster than their peers who did not have cancer, according to…
RNA Splicing Errors Drive Leukemia
By: Staff Writer | January 02, 2026 | 7 min. read | Share Summary A new study from Sylvester Comprehensive…
Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer-driving protein…
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with…
Young donor age proves critical for survival after stem cell transplantation
The selection of suitable donors is crucial for the long-term recovery of patients after an allogeneic hematopoietic stem…
Immune cell dysregulation and inflammatory mediators shape epilepsy risk
Background and objectives Emerging evidence implicates immune dysregulation and neuroinflammation in the pathogenesis of epilepsy, yet the causal…